Atlas Trials

Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients

Clinical trial NCT02866682 · COMPLETED

Trial details

NCT number
NCT02866682
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Transplant Rejection
Start date
2018-03-01
Primary completion
2021-06-11
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.